GIVLAARI vs MYSOLINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. GIVLAARI and MYSOLINE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GIVLAARI	MYSOLINE
Rating	New	74/100
Pharmacy pays	—	~$2.89 /30
Type	RX	RX
Active ingredient	GIVOSIRAN SODIUM	PRIMIDONE
Manufacturer	Alnylam Pharms Inc	Valeant Pharm Intl
Dosage forms	Injectable	Tablet
Drug class	Aminolevulinate Synthase 1-Directed Rna Interaction	Anti-Epileptic Agent
Boxed warning	None	None
Treats	Hepatic Porphyrias	Partial Epilepsies, Tonic-Clonic Epilepsy, Tremor

givlaari mysoline

Rating

New

74/100

Pharmacy pays

—

~$2.89 /30

Type

Active ingredient

GIVOSIRAN SODIUM

PRIMIDONE

Manufacturer

Alnylam Pharms Inc

Valeant Pharm Intl

Dosage forms

Injectable

Tablet

Drug class

Aminolevulinate Synthase 1-Directed Rna Interaction

Anti-Epileptic Agent

Boxed warning

None

Treats

Hepatic Porphyrias

Partial Epilepsies, Tonic-Clonic Epilepsy, Tremor

Frequently asked questions

What is the difference between Givlaari and Mysoline?

Givlaari contains Givosiran Sodium, while Mysoline contains Primidone — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.